Six health organizations and a physician challenge the legality of rescinded vaccine recommendations and dismissal of federal advisory members.
6 plantiffs
Image credits: IDSA
On July 7, 2025, six major medical and public health organizations, along with a pregnant physician, filed a federal lawsuit in the US District Court for the District of Massachusetts against the US Department of Health and Human Services (HHS) and Secretary Robert F Kennedy Jr.
The plaintiffs allege that Secretary Kennedy acted unlawfully when he unilaterally rescinded COVID-19 vaccine recommendations for children and pregnant individuals. The lawsuit also challenges the dismissal of 17 members of the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), who were replaced with individuals previously aligned with anti-vaccine positions.
The lawsuit seeks a preliminary and permanent injunction to reverse the rescission of vaccine recommendations and a declaratory judgment that the actions were unlawful.
Plaintiff organizations include:
The individual plaintiff, a pregnant hospital-based physician, is unable to receive a COVID-19 vaccine booster due to the current federal directive.
“This administration is an existential threat to vaccination in America, and those in charge are only just getting started. If left unchecked, Secretary Kennedy will accomplish his goal of ridding the United States of vaccines, which would unleash a wave of preventable harm on our nation’s children,” said Richard H Hughes IV, partner at Epstein Becker Green and lead counsel for the plaintiffs in the press release. “The professional associations for pediatricians, internal medicine physicians, infectious disease physicians, high-risk pregnancy physicians, and public health professionals will not stand idly by as our system of prevention is dismantled. This ends now.”
The lawsuit asserts that HHS and Secretary Kennedy have undermined public health by:
The plaintiffs argue these changes compromise public confidence and hinder access to evidence-based preventive care. In public statements, leadership from each organization emphasized the impact of the directive on clinical care, patient trust, and public health infrastructure. They called for reinstating science-driven vaccine guidance developed through transparent processes.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.